The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth

  • Published : 2008.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

The influence of alpha-fetoprotein (AFP) on the bone marrow (BM) natural suppressor (NS) cells of intact Ehrlich carcinoma -bearing CBA mice was studied. Bone marrow NS cells were fractionated into three fractions by isopycnic centrifugation on percoll gradients: NS1 (${\rho}$=1.080 g/ml), NS2 (${\rho}$=1.090 g/ml) and NS3 (1.100> ${\rho}$ > 1.090 g/ml). These fractions were highly different in their sensitivity to known NS cell inductors (interleukin (IL)-2, IL-3 or histamine). None of the NS fractions isolated from the intact mice spontaneously produced antiproliferative activity, however, they showed a high level of NS (antiproliferative and natural killer cell inhibitory) activity under the influence of AFP. A single injection of AFP to intact mice led to an increase of spontaneous NS activity and the inhibition of natural killer cell activity. NS activity, especially NS2, was increased in when tumor cells were subcutaneously inoculated three days after AFP injection. In the AFP-treated mice, the tumor mass at 14 days was 60% larger than that in the untreated mice. Our data confirmed that AFP is a tumor marker that can inhibit cancer immunity and plays a role in cancer pathogenesis.

Keywords

References

  1. Abelev GI. Alpha-fetoprotein biology. In: Skulachev VP ed, Soviet Science Review (section D) Physicochemical Biology. Harwood Acad Publ, New York, p 85-109, 1993
  2. Angulo I, Rodriguez R, Garcia B, Medina M, Navarro J, Subiza JL. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. J Immunol 155: 15-26, 1995
  3. Belyaev NN, Zakiryanova GK, Khegai LA, Beklemishev AB. Analysis of antimitogenic and histamine binding functions of bone marrow cell isopycnic fractions. Immunology 3: 15-17 1993 (Rus.)
  4. Cardoso E, Valdez G, Comini E, Matera L. Effect of human alpha-fetoprotein on native and in vitro-stimulated NK activity. J Clin Lab Immunol 34: 183-188, 1991
  5. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Research 47: 936-942, 1987
  6. Chakraborty M, Mandal C. Immuno-supressive effect of human alpha-fetoprotein: a cross species study. Immunol Invest 22: 329-339, 1993 https://doi.org/10.3109/08820139309063412
  7. Holda, JH, Maier T, Claman HN. Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL-2 and interferon-$\gamma$. J Immunol 137: 3538-3543, 1986
  8. Hoskin DW, Murgita RA. Specific maternal anti-fetal lymphoproliferative responses and their regulation by natural immunosuppressive factors. Clin Exp Immunol 76: 262-267, 1989
  9. Moore SC, Theus SA, Barnett JB, Soderberg LS. Cytokine regulation of bone marrow natural suppressor cell activity in the suppression of lymphocyte function. Cell Immunol 141: 398-408, 1992 https://doi.org/10.1016/0008-8749(92)90158-L
  10. Semeniuk DJ, Boismenu R, Tam J, Weissenhofer W, Murgita RA. Evidence that immunosuppression is an intrinsic property of the alpha-fetoprotein molecule. Adv Exp Med Biol 383: 255-269, 1999
  11. Sinenko SA, Belyaev NN, Kuzovlev VD, Khakimzhanov AA. The immunochemical distinctions of human-$\alpha$ fetoprotein preparations as revealed with novel monoclonal antibodies. Reports MS-AS RK 1: 72-80, 1999
  12. Subiza JL, Vinuela JE, Rodriguez R, Gil J, Figueredo MA, De la Concha EG. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int J Cancer 44: 307-314, 1989 https://doi.org/10.1002/ijc.2910440220
  13. Sykes M, Strober S. Mechanisms of tolerance. In: Hematopoietic cell transplantation. 2nd ed. Blackwell Science, Malden, 1999
  14. Yamada A, Hayami M. Suppression of natural killer cell activity by chicken alpha-fetoprotein in Japanease quails. J Natl Cancer Inst 70: 735-738, 1983
  15. Yamaguchi V, Takashima I, Funakoshi M, Kawami H, Toge T. Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor. In Vivo 8: 279-283, 1994
  16. Young MR, Young ME, Wright MA. Stimulation of immune- suppressive bone marrow cells by colony-stimulated factors. Exp Hematol 18: 806-811, 1990
  17. Young MR, Wright MA, Coogan M, Young ME, Bagash J. Tumor- derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta. Cancer Immunol Immunother 35: 14-18, 1992 https://doi.org/10.1007/BF01741049